Detalles de la búsqueda
1.
Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center trial.
Pharmacol Res
; 200: 107052, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181857
2.
[Comparison between Ye Tianshi and Wu Jutong in treatment of summer-heat disease].
Zhongguo Zhong Yao Za Zhi
; 43(18): 3764-3770, 2018 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-30384544
3.
[Application of qualitative interviews in inheritance research of famous old traditional Chinese medicine doctors: ideas and experience].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 35(4): 492-6, 2015 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-26043577
4.
[Ginkgo preparations of Chinese medicine and treatment of diabetes: mechanisms and clinical applications].
Zhongguo Zhong Yao Za Zhi
; 39(23): 4509-15, 2014 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-25911792
5.
[Progress in researches on ancient history of atherosclerosis].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 33(10): 1301-4, 2013 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-24432667
6.
Effects of Qingda granule on patients with grade 1 hypertension at low-medium risk: study protocol for a randomized, controlled, double-blind clinical trial.
Trials
; 24(1): 1, 2023 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36588157
7.
Essential oils for treating anxiety: a systematic review of randomized controlled trials and network meta-analysis.
Front Public Health
; 11: 1144404, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37325306
8.
[Study on the diagnostic criteria for coronary heart disease patients of blood stasis syndrome].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 32(9): 1285-6, 2012 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-23185776
9.
Triglyceride-glucose index and estimated 10-year risk of a first hard cardiovascular event.
Front Cardiovasc Med
; 9: 994329, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698933
10.
Growth factor for therapeutic angiogenesis in ischemic heart disease: A meta-analysis of randomized controlled trials.
Front Cell Dev Biol
; 10: 1095623, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36568984
11.
Association of body mass index trajectory and hypertension risk: A systematic review of cohort studies and network meta-analysis of 89,094 participants.
Front Cardiovasc Med
; 9: 941341, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36684600
12.
Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach.
Chin J Integr Med
; 27(1): 62-69, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32447519
13.
[On Pathogenesis of Coronary Heart Disease from Stasis Induced Toxicity].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 35(11): 1378-80, 2015 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-26775489
14.
[Analysis of relationships among syndrome, therapeutic treatment, and Chinese herbal medicine in patients with coronary artery disease based on complex networks].
Zhong Xi Yi Jie He Xue Bao
; 8(3): 238-43, 2010 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-20226145
15.
Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial.
Chin J Integr Med
; 26(8): 577-582, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32761337
16.
Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial.
Chin J Integr Med
; 23(10): 740-746, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27778264
17.
Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
Exp Biol Med (Maywood)
; 241(5): 478-84, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26585407
18.
Multifactor dimensionality reduction analysis of the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease.
Chin J Integr Med
; 20(5): 341-6, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24599819
19.
Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter Study.
Evid Based Complement Alternat Med
; 2013: 741518, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23935679
20.
Diagnostic criterion of blood stasis syndrome for coronary heart disease : Activating Blood Circulation Committee of Chinese Association of Integrative Medicine.
Chin J Integr Med
; 22(11): 803-804, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27783323